000 | 01939 a2200529 4500 | ||
---|---|---|---|
005 | 20250514051134.0 | ||
264 | 0 | _c20030306 | |
008 | 200303s 0 0 eng d | ||
022 | _a0014-4819 | ||
024 | 7 |
_a10.1007/s00221-002-1182-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aPeeters-Scholte, Cacha | |
245 | 0 | 0 |
_aPharmacological interventions in the newborn piglet in the first 24 h after hypoxia-ischemia. A hemodynamic and electrophysiological perspective. _h[electronic resource] |
260 |
_bExperimental brain research _cNov 2002 |
||
300 |
_a200-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAllopurinol _xpharmacology |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAnimals, Newborn |
650 | 0 | 4 |
_aBiotin _xanalogs & derivatives |
650 | 0 | 4 |
_aCerebral Cortex _xdrug effects |
650 | 0 | 4 |
_aDeferoxamine _xpharmacology |
650 | 0 | 4 | _aElectroencephalography |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aFree Radical Scavengers _xpharmacology |
650 | 0 | 4 |
_aHemoglobins _xmetabolism |
650 | 0 | 4 |
_aHypoxia-Ischemia, Brain _xblood |
650 | 0 | 4 |
_aIron Chelating Agents _xpharmacology |
650 | 0 | 4 |
_aMagnetic Resonance Spectroscopy _xmethods |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 | _aNitric Oxide Synthase Type I |
650 | 0 | 4 | _aNitric Oxide Synthase Type II |
650 | 0 | 4 | _aPhosphorus Radioisotopes |
650 | 0 | 4 | _aSpectrophotometry |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _avan den Tweel, Evelyn | |
700 | 1 | _aIoroi, Tomoaki | |
700 | 1 | _aPost, Ilka | |
700 | 1 | _aBraun, Kees | |
700 | 1 | _aVeldhuis, Wouter | |
700 | 1 | _aNicolay, Klaas | |
700 | 1 | _aGroenendaal, Floris | |
700 | 1 | _avan Bel, Frank | |
773 | 0 |
_tExperimental brain research _gvol. 147 _gno. 2 _gp. 200-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00221-002-1182-x _zAvailable from publisher's website |
999 |
_c12218476 _d12218476 |